Challenges
Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below it, and a solid...
It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...
The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...
With the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases. So it...
The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts...
How difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find themselves...
We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...
It’s a long, hard road that begins with the identification of a promising drug candidate and ends with its introduction to the marketplace. A drug...
With the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors...
“The $1000 Pill.” “The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make.” “A Billion a Year for Costly Drug Treatment.” These eye-catching...
Search
Categories
- Artificial Intelligence (3)
- Challenges (63)
- Discovery & Innovation (193)
- Industry Trends (210)
- Infographics (17)
- News & Events (87)
- Open Science (39)
- Outsourcing (73)
- Press Releases (144)
- Research Exchanges (58)
- Research Services (94)
- Scientist In The News (152)
- Supplier Spotlight (50)
- Tech Snapshot (37)
- Webinars (34)